Carebook Technologies Inc. (V:CRBK)
Business Focus: IT Services & Consulting (NEC)
You may also be interested in
Insider Filings
Latest 10 SEDI filings for CRBK within the last 6 months
See all filings within the past 6 months
Read full article
Read full article
See more news stories
See all valuations
See Short Report
Loading...
Company News
Apr 01, 2024 08:00 ET
Carebook Announces Fiscal 2023 Results
Revenue for the year up 32% to $12.3M for 2023 compared to $9.2M for 2022.Loss from operations for 2023 was $(2.5)M, an improvement of $3.7M, when compared to 2022.Net Loss for 2023 was $(3.3)M , and improvement of $14.5M compared to Net Loss of $(17.8)M for 2022, which included a non-cash impairment of goodwill and intangible assets for a total of $12.5M.Adjusted EBITDA(1) loss of $(1.1)M for 2023, compared to Adjusted EBITDA(1) loss of $(4.1)M for 2022, an improvement of $3.0M. Adjusted EBITDA Margin(1) of (9)% in 2023 compared to (44)% in 2022.ARR(2) of $12.1M as of December 31, 2023, a
Mar 18, 2024 08:00 ET
Carebook to report FY2023 Year End Results
MONTREAL, March 18, 2024 /CNW/ - Carebook Technologies Inc. ("Carebook" or the "Company") (TSXV: CRBK) (OTCPK: CRBKF) (XETR: PMM1), a leading Canadian provider of innovative digital health solutions, will release its financial results for the fiscal year ended December 31, 2023 on Monday, April 1, 2023 prior to market opening. Michael Peters, CEO, and Olivier Giner, CFO will hold a conference call and audio webcast to review the results at 8.30am EST. Carebook cordially invites all interested parties to participate in this call.
Valuation Ratios
Industry
Sector
Beta
0.41
--
--
Price to Sales - TTM
0.44
6.74
4.41
Price to Book - most recent quarter
--
2.52
2.51
Price to Cash Flow per share - TTM
--
11.60
10.87
Price to Free Cash Flow per share - TTM
--
20.09
23.64
Short Report
| Date | Number of Shares Shorted | Net Change |
|---|---|---|
| Apr 15, 2024 | 836 | 800 |
| Mar 31, 2024 | 36 | 0 |
| Mar 15, 2024 | 36 | 0 |
Business Summary
| Sector: Technology | Industry: IT Services & Consulting |
Carebook Technologies Inc. is a Canada-based company. The principal activities of the Company consist of the development and commercialization of complete end-to-end digital health platforms that feature assessments, reporting, and targeted solutions offered through an array of selected partners and resellers, or directly to its primary end customers, which are employers across a variety of industries and pharmacies. The Carebook platforms connect about 3.5 million members to a host of healthcare solutions and providers. It offers pharmacy retailers an all-in-one customer-facing digital platform that brings together medication management, the ability for individuals, families, and caregivers to manage their health information in one spot, health assessments, as well as receive recommendations based on their results to help reduce the risk of chronic diseases, including access to health professional services. Wellness Checkpoint Solution and CoreHealth Solution are its products.
See business summary
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System
for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission.Read less
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Interactive technical study charts by TradingView. Copyright © 2024 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.
